PH30682A - Nutrional product for persons infected with human immunodeficiency virus - Google Patents

Nutrional product for persons infected with human immunodeficiency virus

Info

Publication number
PH30682A
PH30682A PH46849A PH46849A PH30682A PH 30682 A PH30682 A PH 30682A PH 46849 A PH46849 A PH 46849A PH 46849 A PH46849 A PH 46849A PH 30682 A PH30682 A PH 30682A
Authority
PH
Philippines
Prior art keywords
immunodeficiency virus
human immunodeficiency
infected
nutritional product
product
Prior art date
Application number
PH46849A
Other languages
English (en)
Inventor
Frederick O Cope
Normanella T Dewille
Ernest W Richards
Terrence B Mazer
Bonnie C Abbruzzese
Gregor A Snowden
Michael A Chandler
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/069,264 external-priority patent/US5330972A/en
Priority claimed from US08/069,269 external-priority patent/US5403826A/en
Priority claimed from US08/069,066 external-priority patent/US5480872A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PH30682A publication Critical patent/PH30682A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Epidemiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PH46849A 1993-05-28 1993-09-09 Nutrional product for persons infected with human immunodeficiency virus PH30682A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/069,264 US5330972A (en) 1993-05-28 1993-05-28 Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus
US08/069,269 US5403826A (en) 1993-05-28 1993-05-28 Nutritional product for persons infected with human immunodeficiency virus
US08/069,066 US5480872A (en) 1993-05-28 1993-05-28 Method of providing enternal nutritional support to persons infected with human immunodeficiency virus

Publications (1)

Publication Number Publication Date
PH30682A true PH30682A (en) 1997-09-16

Family

ID=27371464

Family Applications (1)

Application Number Title Priority Date Filing Date
PH46849A PH30682A (en) 1993-05-28 1993-09-09 Nutrional product for persons infected with human immunodeficiency virus

Country Status (15)

Country Link
EP (1) EP0626177B1 (de)
JP (1) JPH089545B2 (de)
KR (1) KR970005330B1 (de)
AT (1) ATE187076T1 (de)
AU (1) AU651284B1 (de)
CA (1) CA2105790C (de)
DE (1) DE69327159T2 (de)
DK (1) DK0626177T3 (de)
ES (1) ES2142842T3 (de)
GR (1) GR3032748T3 (de)
IL (1) IL106975A (de)
NZ (1) NZ248603A (de)
PH (1) PH30682A (de)
PT (1) PT626177E (de)
TW (1) TW492867B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US5759548A (en) 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
WO1997009989A1 (en) * 1995-09-14 1997-03-20 Lxr Biotechnology Inc. Compositions with anti-apoptotic activity, containing a mixture of phospholipids
US5681600A (en) * 1995-12-18 1997-10-28 Abbott Laboratories Stabilization of liquid nutritional products and method of making
US5866606A (en) * 1996-07-31 1999-02-02 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as anti-microbial agents
US5958974A (en) * 1996-07-31 1999-09-28 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents
DE69715637T2 (de) * 1996-07-31 2003-08-07 Abbott Laboratories, Abbott Park Mit wasser mischbare monoglyceridester mit antimikrobieller aktivität
US5981587A (en) * 1996-07-31 1999-11-09 Abbott Laboratories Water-miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
US5908862A (en) * 1996-07-31 1999-06-01 Abbot Laboratories Water-miscible esters of mono--and diglycerides having antibacterial activity and their use in inhibiting infection
US6495532B1 (en) 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6200950B1 (en) * 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
US6413556B1 (en) 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
EP1236405B1 (de) * 2001-03-01 2006-06-21 Societe Des Produits Nestle S.A. Hypoallergene Nahrungsmittel zur Induzierung oraler Toleranz gegenüber Sojaproteinen
EP1281325A1 (de) * 2001-07-30 2003-02-05 Societe Des Produits Nestle S.A. Ernährungszusammensetzung zur Unterdrückung von bakteriellem Wachstum
JP4554149B2 (ja) * 2002-11-28 2010-09-29 雅美 森山 レトロウイルス感染症治療薬
CA2534822C (en) * 2003-09-10 2012-02-21 Unilever Plc Food composition comprising fat, and emulsifier mixture, and transition metals, divalent metals or compounds thereof
SI1758469T2 (sl) * 2004-06-22 2013-12-31 N.V.Nutricia Izboljšanje integritete bariere pri HIV pacientih z uporabo maščobnih kislin
EP1723951A1 (de) † 2005-04-21 2006-11-22 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
JP5098198B2 (ja) * 2005-03-28 2012-12-12 大正製薬株式会社 銅化合物配合組成物
EP1972345B1 (de) * 2005-11-30 2014-08-13 Vegenat, S.A. Nahrungsprodukt zur enteralen oder oralen ernährung
EP1972346B1 (de) * 2005-11-30 2015-10-14 Vegenat, S.A. Proteinmischung und ihre verwendung bei der herstellung eines produkts zur verwendung als orales oder enterales nahrungsmittel
EP1964554A1 (de) * 2005-11-30 2008-09-03 Katry Inversiones, S.L. Lipid-gemisch und seine verwendung zur herstellung eines produkts zur enteralen oder oralen verabreichung
BRPI0621285A2 (pt) * 2006-01-31 2011-12-06 Parsroos Co. método para a preparação de um extrato vegetal e processo de produção de uma composição farmacêutica para estìmulo imunológico e/ou tratamento de infecções por hiv que compreende o referido extrato vegetal
JP2007246509A (ja) * 2006-02-16 2007-09-27 Taisho Pharmaceut Co Ltd 銅化合物配合経口用組成物
JP5181486B2 (ja) * 2006-02-16 2013-04-10 大正製薬株式会社 亜鉛化合物配合経口用組成物
BRPI0914023A2 (pt) * 2008-10-10 2016-07-26 Solae Llc composição nutricional e método para fornecer uma nutrição
US20190335796A1 (en) * 2014-09-01 2019-11-07 Jolly Mathew Vadakkemuri Optimized nutrient food

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE65406T1 (de) * 1985-01-29 1991-08-15 Abbott Lab Enterales hypoallergenisches ernaehrungsrezept.
SE8601828D0 (sv) * 1986-04-21 1986-04-21 Novo Industri As Enteral diet product and agent for production thereof
DE3785667T2 (de) * 1986-09-17 1994-07-21 Clintec Nutrition Co Zusatznahrung bzw. therapie für personen mit risiko oder in behandlung für arteriosklerotische vaskuläre, kardiovaskuläre und/oder thrombotische erkrankungen.
DK3991D0 (da) * 1991-01-10 1991-01-10 Novo Nordisk As Fremgangsmaade til fremstilling af et proteinhydrolysat
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat

Also Published As

Publication number Publication date
IL106975A0 (en) 1993-12-28
EP0626177A2 (de) 1994-11-30
DE69327159T2 (de) 2000-07-13
AU651284B1 (en) 1994-07-14
JPH06340545A (ja) 1994-12-13
EP0626177B1 (de) 1999-12-01
TW492867B (en) 2002-07-01
CA2105790A1 (en) 1994-11-29
CA2105790C (en) 1998-07-28
ATE187076T1 (de) 1999-12-15
EP0626177A3 (de) 1995-02-22
KR970005330B1 (ko) 1997-04-15
ES2142842T3 (es) 2000-05-01
PT626177E (pt) 2000-05-31
GR3032748T3 (en) 2000-06-30
DE69327159D1 (de) 2000-01-05
IL106975A (en) 1996-01-19
DK0626177T3 (da) 2000-05-08
NZ248603A (en) 1994-12-22
JPH089545B2 (ja) 1996-01-31

Similar Documents

Publication Publication Date Title
GR3032748T3 (en) Nutrition for persons infected with human immunodeficiency virus.
CA2372614A1 (en) Process and product for enhancing immune response in companion animal using a combination of antioxidants
MY112705A (en) Tryglycerides
DE69331528D1 (de) Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
CA2054358A1 (en) High acid nutritional formulations
ATE147592T1 (de) Vitamine und mineralien enthaltende nahrungszusätze
BR9712259A (pt) Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.
CA2105791A1 (en) Nutrition for Persons Undergoing Radiation Therapy and/or Chemotherapy
HUP9800049A3 (en) Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf
IL67978A0 (en) Human immune interferon,its preparation and purification and pharmaceutical compositions containing it
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
CA2133610A1 (en) Additive for Use in Feed for Sows and Feed for Sows
FR2656309B1 (fr) Nouveaux produits sterouides comportant en position 10, un radical ethyle substitue, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
WO1988003150A3 (en) N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
ATE178615T1 (de) Verwendung eines dekapeptids mit benzodiazepinischer wirkung zur herstellung von arzneimitteln und diätzusätzen
AU601787B2 (en) Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxy-acetic acids, new intermediate products, processes for their preparation and their use as medicaments
ZA932748B (en) Water-soluble retinoids
EP0304897A3 (de) Mittel zur Immunisierung des menschlichen Körpers bei HIV-Infektionen
AU609435B2 (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon
TH5361S1 (th) ที่ป้อนน้ำผลไม้
TH8505S (th) ที่ป้อนน้ำผลไม้
Kojima Gastrointestinal absorption of cadmium.
IT8920225A0 (it) Integratori dietetici, in particolare per condizioni di accresciuto catabolismo proteico.
Klokova et al. Effects of hyperbaric oxygenation on activation of immunocompetent cells and lipid peroxidation under immunization by heterologous erythrocytes
Fukayama Immunological responses in the aged with bacterial infection